Search Results

240 results for NOVL

Lemons for Lulu, Barnes & Noble: Thursday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger

Barnes & Noble (BKS), Lululemon Athletica (LULU) take a licking after disappointing earnings reports Thursday.

Chinese E-Reader Shows Way for Amazon, Barnes & Noble

By Anthony John Agnello, Consumer and Technology Writer

The next Kindle and Nook will have to incorporate more color and size.

Downside Activity in Burnt-Out SunPower, NovaGold

By Mike Yamamoto, optionMonster

Options traders are buying puts in SunPower Corp. (NASDAQ: SPWRA) and NovaGold Resources (AMEX: NG).

Should You Buy Into the Barnes & Noble E-Book Hype?

By Louis Navellier, Editor, Growth Investor

Microsoft’s investment in the Barnes and Noble NOOK e-reader will give both firms the ability to take advantage of a growing market, but is it…

Why Is Barnes & Noble (BNED) Stock Down 16% Today?

By William White, InvestorPlace Writer

Barnes & Noble Education stock is down on Monday after shares of BNED underwent a massive rally on Friday alongside interest news.

What Is Going on With Barnes & Noble Education (BNED) Stock Today?

By Shrey Dua, InvestorPlace Senior Financial News Reporter

BNED stock can’t stop climbing today, closing up by more than 70% and continuing last Friday’s rally. What’s up with Barnes and Noble lately?

Why Is Vivani Medical (VANI) Stock Up 300% Today?

By Josh Enomoto, InvestorPlace Contributor

With Vivani Medical introducing pre-clinical efficacy data for its weight-loss solution, VANI stock soared on the broader implications.

45 Blue-Chip Stocks Increasing Dividends in Q3 2013

By Kyle Woodley, Senior Investing Editor, Kiplinger

These 45 blue chips pleased income investors during Q3 by announcing bigger quarterly dividends — and some of them have yet to go ex-dividend.

9 Biotechnology Stocks to Buy Now

By Portfolio Grader

This week, nine biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).

9 Biotechnology Stocks to Buy Now

By Portfolio Grader

This week, nine biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).

Structure Therapeutics (GPCR) Stock Soars 60% on Weight Loss Drug Success

By Shrey Dua, InvestorPlace Senior Financial News Reporter

GPCR stock shot up 60% today after Structure Therapeutics announced positive data from its mid-stage weight loss pill trials.

Call Spread: National-Oilwell Varco (NOV)

By Tyler Craig, Tales of a Technician

The oil and gas SPDR shows great relative strength, but has low options liquidity. Try a spread in one of its components, NOV, to leverage…

What Does Buffett See in NOV, PSX?

By Dan Burrows, InvestorPlace Feature Writer

Berkshire Hathaway dumped Intel and pared back J&J and P&G — but the more interesting moves were its two buys in the energy sector.

Hop Aboard NSC Nov 60 Calls

By Chris Johnson and Jon Lewis, Contributors

Norfolk Southern Corp. (NYSE: NSC) should be the next railroad company to deliver a positive earnings report.

40 Blue Chips Increasing Dividends in Q3 2012

By Kyle Woodley, Senior Investing Editor, Kiplinger

Hunting stability and yield? Check out these dividend-hiking heroes that rewarded shareholders during Q3.

Carnival Stock Slips 6% on Another Mardi Gras Delay

By William White, InvestorPlace Writer

Carnival (CCL) stock is falling on Tuesday after announcing that its new Mardi Gras ship is facing a delay pushing its launch into 2021.

7 Stocks to Watch as Omicron Takes Aim at the Holiday Travel Recovery Story

By Josh Enomoto, InvestorPlace Contributor

With the omicron variant of the novel coronavirus imposing a dark cloud over the travel industry, these are the stocks to watch.

The 7 Best Tech Stocks to Buy Heading Into Q4

By Josh Enomoto, InvestorPlace Contributor

Due to the massive disruption of the novel coronavirus pandemic, these are the tech stocks to watch heading into Q4.

8 Pet Stocks That Will Make You Purr

By Josh Enomoto, InvestorPlace Contributor

Americans love their pets, and no pandemic, not even the novel coronavirus, will change that, bolstering these eight pet stocks.

7 Telehealth Stocks That Have Plenty of Growth On Tap

By Ian Bezek, InvestorPlace Contributor

The novel coronavirus exposed weaknesses in the healthcare system. These telehealth stocks are leading the effort to modernize healthcare.

FarmTogether: Save Your Portfolio From Coronavirus, Invest in U.S. Farmland

By Luke Lango, InvestorPlace Senior Investment Analyst

FarmTogether could be the perfect antidote for your volatile portfolio during the novel coronavirus pandemic.

Starbucks Stock Is Worth Clinging On To During This Transition Period

By Louis Navellier and the InvestorPlace Research Staff

The novel coronavirus poses major challenges to Starbucks and SBUX stock, but it can endure and move forward.

Disney Is Streaming Above the Bad News

By Dana Blankenhorn, InvestorPlace Contributor

The price of Disney stock doesn’t reflect the negative impact of the novel coronavirus on the entertainment company.

Investor Alert: 3 Fintech Stocks Ready to Roar

By Muslim Farooque, InvestorPlace Contributor

Explore the top fintech stocks to buy, navigating through a merger of traditional and novel financial practices.

9 – 10 of 240 results